tirzepatide benefits other than weight loss GLP-1 Medications for Loss: Semaglutide vs vs Retat – Revolution Health & Wellness Semaglutide vs. Tirzepatide: Which Weight

As obesity and related chronic conditions continue to impact millions of older Americans, this initiative could play a transformative role in improving health outcomes and reshaping how Medicare addresses weight management

In the EVOKE studies, the mean age was 72.2 years

By week 8, mean body weight reduction reached 9.1%(9.6 kg), with waist circumference reduced by 9.8 cm(3.8 inches)

In these very high-risk patients, GLP-1 receptor agonists reduce overall mortality, with an NNT of 42 (95% CI, 29 to 84) over five years

Prolonged Redness: Erythema lasting 5-7 days instead of the typical 24-48 hours in non-pregnant patients 3